These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


162 related items for PubMed ID: 22341782

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Rabies virus expressing dendritic cell-activating molecules enhances the innate and adaptive immune response to vaccination.
    Wen Y, Wang H, Wu H, Yang F, Tripp RA, Hogan RJ, Fu ZF.
    J Virol; 2011 Feb; 85(4):1634-44. PubMed ID: 21106736
    [Abstract] [Full Text] [Related]

  • 4. Comparative ability of various plasmid-based cytokines and chemokines to adjuvant the activity of HIV plasmid DNA vaccines.
    Xu R, Megati S, Roopchand V, Luckay A, Masood A, Garcia-Hand D, Rosati M, Weiner DB, Felber BK, Pavlakis GN, Sidhu MK, Eldridge JH, Egan MA.
    Vaccine; 2008 Sep 02; 26(37):4819-29. PubMed ID: 18657584
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Recombinant rabies viruses expressing GM-CSF or flagellin are effective vaccines for both intramuscular and oral immunizations.
    Zhou M, Zhang G, Ren G, Gnanadurai CW, Li Z, Chai Q, Yang Y, Leyson CM, Wu W, Cui M, Fu ZF.
    PLoS One; 2013 Sep 02; 8(5):e63384. PubMed ID: 23700422
    [Abstract] [Full Text] [Related]

  • 7. Dendritic cells infected by recombinant rabies virus vaccine vector expressing HIV-1 Gag are immunogenic even in the presence of vector-specific immunity.
    Wanjalla CN, Faul EJ, Gomme EA, Schnell MJ.
    Vaccine; 2010 Dec 10; 29(1):130-40. PubMed ID: 20728525
    [Abstract] [Full Text] [Related]

  • 8. Interferon-beta expressed by a rabies virus-based HIV-1 vaccine vector serves as a molecular adjuvant and decreases pathogenicity.
    Faul EJ, Wanjalla CN, McGettigan JP, Schnell MJ.
    Virology; 2008 Dec 20; 382(2):226-38. PubMed ID: 18945463
    [Abstract] [Full Text] [Related]

  • 9. Expression of interleukin-6 by a recombinant rabies virus enhances its immunogenicity as a potential vaccine.
    Luo J, Zhang B, Wu Y, Tian Q, Zhao J, Lyu Z, Zhang Q, Mei M, Luo Y, Guo X.
    Vaccine; 2017 Feb 07; 35(6):938-944. PubMed ID: 28089546
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Recombinant rabies virus expressing dog GM-CSF is an efficacious oral rabies vaccine for dogs.
    Zhou M, Wang L, Zhou S, Wang Z, Ruan J, Tang L, Jia Z, Cui M, Zhao L, Fu ZF.
    Oncotarget; 2015 Nov 17; 6(36):38504-16. PubMed ID: 26436700
    [Abstract] [Full Text] [Related]

  • 12. Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF.
    Barouch DH, Santra S, Tenner-Racz K, Racz P, Kuroda MJ, Schmitz JE, Jackson SS, Lifton MA, Freed DC, Perry HC, Davies ME, Shiver JW, Letvin NL.
    J Immunol; 2002 Jan 15; 168(2):562-8. PubMed ID: 11777947
    [Abstract] [Full Text] [Related]

  • 13. Dendritic cells generated in the presence of granulocyte-macrophage colony-stimulating factor and IFN-alpha are potent inducers of HIV-specific CD8 T cells.
    Carbonneil C, Aouba A, Burgard M, Cardinaud S, Rouzioux C, Langlade-Demoyen P, Weiss L.
    AIDS; 2003 Aug 15; 17(12):1731-40. PubMed ID: 12891059
    [Abstract] [Full Text] [Related]

  • 14. Granulocyte/macrophage-colony stimulating factor produced by recombinant avian poxviruses enriches the regional lymph nodes with antigen-presenting cells and acts as an immunoadjuvant.
    Kass E, Panicali DL, Mazzara G, Schlom J, Greiner JW.
    Cancer Res; 2001 Jan 01; 61(1):206-14. PubMed ID: 11196163
    [Abstract] [Full Text] [Related]

  • 15. Intramuscular immunization with a monogenic plasmid DNA tuberculosis vaccine: Enhanced immunogenicity by electroporation and co-expression of GM-CSF transgene.
    Zhang X, Divangahi M, Ngai P, Santosuosso M, Millar J, Zganiacz A, Wang J, Bramson J, Xing Z.
    Vaccine; 2007 Jan 26; 25(7):1342-52. PubMed ID: 17052817
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A Novel Rabies Vaccine Expressing CXCL13 Enhances Humoral Immunity by Recruiting both T Follicular Helper and Germinal Center B Cells.
    Wang Z, Li M, Zhou M, Zhang Y, Yang J, Cao Y, Wang K, Cui M, Chen H, Fu ZF, Zhao L.
    J Virol; 2017 Feb 01; 91(3):. PubMed ID: 27852854
    [Abstract] [Full Text] [Related]

  • 18. A human immunodeficiency virus type 1 Env-granulocyte-macrophage colony-stimulating factor fusion protein enhances the cellular immune response to Env in a vaccinia virus-based vaccine.
    Rodr Guez D, Rodr Guez JR, Llorente M, V Zquez I, Lucas P, Esteban M, Mart Nez-A C, Del Real G.
    J Gen Virol; 1999 Jan 01; 80 ( Pt 1)():217-223. PubMed ID: 9934705
    [Abstract] [Full Text] [Related]

  • 19. Granulocyte-macrophage colony-stimulating factor, a potent adjuvant for polarization to Th-17 pattern: an experience on HIV-1 vaccine model.
    Mahdavi M, Tajik AH, Ebtekar M, Rahimi R, Adibzadeh MM, Moozarmpour HR, Beikverdi MS, Olfat S, Hassan ZM, Choopani M, Kameli M, Hartoonian C.
    APMIS; 2017 Jun 01; 125(6):596-603. PubMed ID: 28493367
    [Abstract] [Full Text] [Related]

  • 20. Injection of DNA encoding granulocyte-macrophage colony-stimulating factor recruits dendritic cells for immune adjuvant effects.
    Bowne WB, Wolchok JD, Hawkins WG, Srinivasan R, Gregor P, Blachere NE, Moroi Y, Engelhorn ME, Houghton AN, Lewis JJ.
    Cytokines Cell Mol Ther; 1999 Dec 01; 5(4):217-25. PubMed ID: 10850386
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.